ADPT
HealthcareAdaptive Biotechnologies Corporation
$13.03+0.58 (+4.68%)
Prev Close
$12.45
Open
$13.05
High
$13.28
Low
$12.69
Volume
3.31M
Market Cap
$2.31B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Adaptive Biotechnologies Corporation (ADPT) has been exclusively selling, with 0 insider purchases totaling $0.00 and 36 insider sales totaling $56.53M. The most recent insider transaction was by RUBINSTEIN JULIE (officer: President and COO), who sold $1.21M worth of shares on Mar 10, 2026. Adaptive Biotechnologies Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.31B.
Buys (12M)
0
$0.00
Sells (12M)
36
$56.53M
Net Activity
Net Seller
$56.53M
Active Insiders
8
last 12 mo
ADPT Price Chart
ADPT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026↗ | RUBINSTEIN JULIE | officer: President and COO | Sell | 81,342 | $14.90 | $1.21M | 652,147 |
| Mar 9, 2026↗ | LO FRANCIS | officer: Chief People Officer | Sell | 38,074 | $15.09 | $574.5K | 321,967 |
| Mar 5, 2026↗ | GRIFFIN MICHELLE RENEE | director | Sell | 48,044 | $15.30 | $735.1K | 15,394 |
| Mar 5, 2026↗ | RUBINSTEIN JULIE | officer: President and COO | Sell | 92,823 | $16.09 | $1.49M | 590,429 |
| Mar 4, 2026↗ | ROBINS HARLAN S | officer: Chief Scientific Officer | Sell | 48,466 | $16.19 | $784.7K | 1,169,520 |
| Mar 3, 2026↗ | ROBINS CHAD M | director, officer: CEO and Chairman | Sell | 1,049,996 | $15.85 | $16.64M | 2,276,350 |
| Feb 6, 2026↗ | PISKEL KYLE | officer: Chief Financial Officer | Sell | 2,145 | $18.46 | $39.6K | 216,637 |
| Feb 4, 2026↗ | PISKEL KYLE | Chief Financial Officer | Sell | 2,145 | $18.46 | $39.6K | 0 |
| Feb 4, 2026↗ | ROBINS CHAD M | director, officer: CEO and Chairman | Sell | 124,998 | $18.44 | $2.30M | 2,459,240 |
| Feb 4, 2026↗ | ROBINS HARLAN S | officer: Chief Scientific Officer | Sell | 42,788 | $18.68 | $799.1K | 1,187,640 |
| Feb 2, 2026↗ | ROBINS CHAD M | CEO and Chairman | Sell | 124,998 | $18.44 | $2.30M | 0 |
| Feb 2, 2026↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 42,788 | $18.68 | $799.1K | 0 |
| Jan 14, 2026↗ | LO FRANCIS | officer: Chief People Officer | Sell | 79,590 | $17.73 | $1.41M | 315,978 |
| Jan 14, 2026↗ | PISKEL KYLE | officer: Chief Financial Officer | Sell | 4,290 | $18.00 | $77.2K | 216,637 |
| Jan 12, 2026↗ | LO FRANCIS | Chief People Officer | Sell | 79,590 | $17.73 | $1.41M | 0 |
| Jan 12, 2026↗ | PISKEL KYLE | Chief Financial Officer | Sell | 4,290 | $18.00 | $77.2K | 0 |
| Jan 8, 2026↗ | ROBINS HARLAN S | officer: Chief Scientific Officer | Sell | 10,000 | $16.44 | $164.4K | 1,222,310 |
| Jan 7, 2026↗ | ROBINS CHAD M | director, officer: CEO and Chairman | Sell | 124,998 | $15.59 | $1.95M | 2,584,240 |
| Jan 6, 2026↗ | LO FRANCIS | officer: Chief People Officer | Sell | 3,125 | $16.08 | $50.3K | 315,978 |
| Jan 6, 2026↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 10,000 | $16.44 | $164.4K | 0 |
| Jan 5, 2026↗ | ROBINS CHAD M | CEO and Chairman | Sell | 124,998 | $15.59 | $1.95M | 0 |
| Jan 2, 2026↗ | LO FRANCIS | Chief People Officer | Sell | 3,125 | $16.08 | $50.3K | 0 |
| Dec 22, 2025↗ | LO FRANCIS | Chief People Officer | Sell | 4,394 | $17.50 | $76.9K | 0 |
| Dec 15, 2025↗ | LO FRANCIS | Chief People Officer | Sell | 113,890 | $15.57 | $1.77M | 0 |
| Dec 10, 2025↗ | HERSHBERG ROBERT | Director | Sell | 22,968 | $16.00 | $367.5K | 0 |
| Dec 4, 2025↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 12,604 | $16.85 | $212.4K | 0 |
| Dec 3, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 37,212 | $18.07 | $672.5K | 0 |
| Nov 28, 2025↗ | PISKEL KYLE | Chief Financial Officer | Sell | 162,820 | $19.50 | $3.17M | 0 |
| Nov 26, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 160,734 | $19.10 | $3.07M | 0 |
| Nov 20, 2025↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 606,402 | $16.73 | $10.14M | 0 |
| Nov 17, 2025↗ | PISKEL KYLE | Chief Financial Officer | Sell | 238 | $14.05 | $3.3K | 0 |
| Nov 10, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 89,265 | $14.73 | $1.32M | 0 |
| Nov 10, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 10,000 | $14.82 | $148.2K | 0 |
| May 15, 2025↗ | PISKEL KYLE | Chief Financial Officer | Sell | 1,929 | $8.89 | $17.1K | 0 |
| May 1, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 68,412 | $7.35 | $502.8K | 0 |
| Mar 24, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 1,698 | $9.00 | $15.3K | 0 |
| Mar 13, 2025↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 36,291 | $7.19 | $260.9K | 0 |
| Mar 12, 2025↗ | HERSHBERG ROBERT | Director | Sell | 53,000 | $7.59 | $402.3K | 0 |
| Mar 10, 2025↗ | NEUPERT PETER M | Director | Sell | 10,000 | $7.05 | $70.5K | 0 |
| Mar 4, 2025↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 44,665 | $6.98 | $311.8K | 0 |
| Mar 4, 2025↗ | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 26,023 | $6.98 | $181.6K | 0 |
| Mar 4, 2025↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 15,664 | $7.94 | $124.4K | 0 |
| Mar 4, 2025↗ | LO FRANCIS | Chief People Officer | Sell | 20,875 | $6.99 | $145.8K | 0 |
| Mar 4, 2025↗ | PISKEL KYLE | Chief Financial Officer | Sell | 10,320 | $6.98 | $72.1K | 0 |
| Mar 4, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 219,569 | $7.29 | $1.60M | 0 |
| Mar 4, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 96,656 | $6.99 | $675.2K | 0 |
| Mar 4, 2025↗ | RUBINSTEIN JULIE | President and COO | Sell | 59,505 | $6.98 | $415.5K | 0 |
| Feb 19, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 285,187 | $8.45 | $2.41M | 0 |
| Feb 13, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 470,368 | $8.47 | $3.99M | 0 |
| Nov 18, 2024↗ | PISKEL KYLE | Chief Financial Officer | Sell | 248 | $4.98 | $1.2K | 0 |
| Aug 22, 2024↗ | Taylor Stacy L | SVP and General Counsel | Sell | 26,922 | $4.50 | $121.1K | 0 |
| Mar 4, 2024↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 29,390 | $3.44 | $101.0K | 0 |
| Mar 4, 2024↗ | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 12,991 | $3.44 | $44.6K | 0 |
| Mar 4, 2024↗ | LO FRANCIS | Chief People Officer | Sell | 14,700 | $3.43 | $50.4K | 0 |
| Mar 4, 2024↗ | PETERSON TYCHO | Chief Financial Officer | Sell | 15,456 | $3.44 | $53.2K | 0 |
| Mar 4, 2024↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 7,727 | $3.43 | $26.5K | 0 |
| Mar 4, 2024↗ | ROBINS CHAD M | CEO and Chairman | Sell | 48,673 | $3.43 | $167.0K | 0 |
| Mar 4, 2024↗ | RUBINSTEIN JULIE | President | Sell | 39,070 | $3.47 | $135.8K | 0 |
| Mar 4, 2024↗ | Taylor Stacy L | SVP and General Counsel | Sell | 13,381 | $3.43 | $46.0K | 0 |
| Nov 16, 2023↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 259 | $4.13 | $1.1K | 0 |
| Aug 7, 2023↗ | SOOD NITIN | Chief Commercial Officer, MRD | Sell | 16,202 | $6.62 | $107.3K | 0 |
| Jun 20, 2023↗ | PETERSON TYCHO | Chief Financial Officer | Sell | 134,961 | $8.14 | $1.10M | 0 |
| Jun 15, 2023↗ | PETERSON TYCHO | Chief Financial Officer | Sell | 70,000 | $8.53 | $597.1K | 0 |
| Jun 2, 2023↗ | PETERSON TYCHO | Chief Financial Officer | Sell | 38,000 | $7.16 | $272.1K | 0 |
| Apr 10, 2023↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $8.60 | $26.9K | 0 |
| Mar 27, 2023↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 2,341 | $8.49 | $19.9K | 0 |
| Mar 6, 2023↗ | ADAMS R MARK | Chief Operating Officer | Sell | 23,684 | $8.59 | $203.5K | 0 |
| Mar 6, 2023↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 11,749 | $8.57 | $100.7K | 0 |
| Mar 6, 2023↗ | LO FRANCIS | Chief People Officer | Sell | 6,816 | $8.57 | $58.4K | 0 |
| Mar 6, 2023↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 3,529 | $8.57 | $30.2K | 0 |
| Mar 6, 2023↗ | RUBINSTEIN JULIE | President | Sell | 22,668 | $8.57 | $194.3K | 0 |
| Mar 6, 2023↗ | SOOD NITIN | Chief Commercial Officer, MRD | Sell | 16,474 | $8.59 | $141.5K | 0 |
| Mar 6, 2023↗ | Taylor Stacy L | SVP and General Counsel | Sell | 18,878 | $8.59 | $162.2K | 0 |
| Jan 9, 2023↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $8.55 | $26.7K | 0 |
| Nov 16, 2022↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 959 | $8.87 | $8.5K | 0 |
| Nov 1, 2022↗ | SOOD NITIN | Chief Commercial Officer, MRD | Sell | 31,066 | $8.00 | $248.5K | 0 |
| Oct 7, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $7.26 | $22.7K | 0 |
| Aug 5, 2022↗ | SOOD NITIN | Chief Commercial Officer, MRD | Sell | 17,540 | $10.98 | $192.6K | 0 |
| Jul 7, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $10.22 | $31.9K | 0 |
| Apr 7, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 831 | $13.17 | $10.9K | 0 |
| Mar 8, 2022↗ | BALDO LANCE | Chief Medical Officer | Sell | 3,350 | $11.43 | $38.3K | 0 |
| Mar 8, 2022↗ | LO FRANCIS | Chief People Officer | Sell | 3,582 | $11.44 | $41.0K | 0 |
| Mar 8, 2022↗ | Taylor Stacy L | SVP and General Counsel | Sell | 2,387 | $11.44 | $27.3K | 0 |
| Mar 7, 2022↗ | BALDO LANCE | Chief Medical Officer | Sell | 2,373 | $12.01 | $28.5K | 0 |
| Mar 7, 2022↗ | ROBINS CHAD M | CEO and Chairman | Sell | 44,445 | $11.80 | $524.4K | 0 |
| Mar 4, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 1,244 | $12.01 | $14.9K | 0 |
| Mar 4, 2022↗ | BENZENO SHARON | Chief Business Development Off | Sell | 2,670 | $12.01 | $32.1K | 0 |
| Mar 4, 2022↗ | LO FRANCIS | Chief People Officer | Sell | 1,569 | $12.01 | $18.8K | 0 |
| Mar 4, 2022↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 220 | $12.01 | $2.6K | 0 |
| Mar 4, 2022↗ | ROBINS CHAD M | CEO and Chairman | Sell | 4,424 | $12.01 | $53.1K | 0 |
| Mar 4, 2022↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 4,517 | $12.01 | $54.2K | 0 |
| Mar 4, 2022↗ | RUBINSTEIN JULIE | President | Sell | 4,613 | $12.01 | $55.4K | 0 |
| Mar 4, 2022↗ | Taylor Stacy L | SVP and General Counsel | Sell | 1,569 | $12.01 | $18.8K | 0 |
| Jan 7, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 1,021 | $23.32 | $23.8K | 0 |
| Dec 22, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $30.00 | $300.0K | 0 |
| Dec 22, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 15,338 | $30.00 | $460.1K | 0 |
| Nov 17, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 4,000 | $32.00 | $128.0K | 0 |
| Nov 9, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $34.98 | $349.8K | 0 |
| Oct 19, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,200 | $33.71 | $377.6K | 0 |
| Oct 7, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $33.16 | $103.6K | 0 |
| Oct 6, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $32.95 | $385.0K | 0 |
| Oct 5, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $32.41 | $324.1K | 0 |
| Sep 13, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $36.98 | $432.1K | 0 |
| Sep 8, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 43,499 | $38.43 | $1.67M | 0 |
| Sep 7, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 14,375 | $39.47 | $567.3K | 0 |
| Sep 7, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 495 | $40.00 | $19.8K | 0 |
| Aug 27, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 14,916 | $35.00 | $522.1K | 0 |
| Aug 25, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $34.25 | $400.2K | 0 |
| Aug 10, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 15,000 | $34.07 | $511.0K | 0 |
| Jul 19, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | Sell | 651 | $36.12 | $23.5K | 0 |
| Jul 19, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $37.47 | $437.9K | 0 |
| Jul 14, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 2,500 | $36.80 | $92.0K | 0 |
| Jul 12, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 1,501 | $38.24 | $57.4K | 0 |
| Jul 7, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $37.17 | $116.2K | 0 |
| Jul 6, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 20,000 | $38.68 | $773.6K | 0 |
| Jun 30, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 4,167 | $41.42 | $172.6K | 0 |
| Jun 17, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 14,583 | $40.00 | $583.3K | 0 |
| Jun 17, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 4,000 | $40.00 | $160.0K | 0 |
| Jun 17, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | Sell | 1,952 | $39.87 | $77.8K | 0 |
| Jun 17, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 4,166 | $40.00 | $166.6K | 0 |
| Jun 15, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 30,000 | $38.47 | $1.15M | 0 |
| Jun 14, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 8,914 | $38.77 | $345.6K | 0 |
| Jun 14, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 2,500 | $38.56 | $96.4K | 0 |
| Jun 9, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $37.32 | $436.1K | 0 |
| Jun 8, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 20,000 | $36.33 | $726.5K | 0 |
| May 18, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 2,500 | $35.00 | $87.5K | 0 |
| May 18, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | Sell | 651 | $35.00 | $22.8K | 0 |
| May 14, 2021↗ | LO FRANCIS | Chief People Officer | Sell | 2,000 | $33.80 | $67.6K | 0 |
| May 11, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 20,000 | $32.08 | $641.6K | 0 |
| May 5, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 7,090 | $35.58 | $252.2K | 0 |
| May 4, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 3,895 | $36.14 | $140.7K | 0 |
| Apr 30, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 4,166 | $41.93 | $174.7K | 0 |
| Apr 20, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 27,265 | $41.56 | $1.13M | 0 |
| Apr 19, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | Sell | 1,301 | $41.25 | $53.7K | 0 |
| Apr 15, 2021↗ | LO FRANCIS | Chief People Officer | Sell | 2,000 | $43.04 | $86.1K | 0 |
| Apr 14, 2021↗ | BALDO LANCE | Chief Medical Officer | Sell | 2,000 | $44.50 | $89.0K | 0 |
| Apr 14, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 4,500 | $43.41 | $195.3K | 0 |
| Apr 7, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,586 | $42.34 | $151.8K | 0 |
| Apr 6, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 20,000 | $41.30 | $826.0K | 0 |
| Apr 6, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 15,000 | $41.81 | $627.1K | 0 |
| Mar 31, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 4,167 | $40.00 | $166.7K | 0 |
| Mar 23, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 19,475 | $40.36 | $786.1K | 0 |
| Mar 18, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, immunoSEQ Dx | Sell | 16,052 | $43.58 | $699.6K | 0 |
| Mar 17, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 15,000 | $42.89 | $643.4K | 0 |
| Mar 15, 2021↗ | BENZENO SHARON | Chief Business Development Off | Sell | 1,354 | $41.69 | $56.5K | 0 |
| Mar 15, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 6,000 | $43.06 | $258.4K | 0 |
| Mar 15, 2021↗ | LO FRANCIS | Chief People Officer | Sell | 2,000 | $41.83 | $83.7K | 0 |
| Mar 10, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $42.54 | $425.4K | 0 |
| Mar 9, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $40.24 | $402.4K | 0 |
| Mar 8, 2021↗ | GOEL DAVID E. | Director | Sell | 806,000 | $39.99 | $32.23M | 0 |
| Mar 8, 2021↗ | HERSHBERG ROBERT | Director | Sell | 4,000 | $44.56 | $178.2K | 0 |
| Mar 1, 2021↗ | BENZENO SHARON | Chief Business Development Off | Sell | 6,771 | $57.62 | $390.1K | 0 |
| Mar 1, 2021↗ | Pellini Michael J | Director | Sell | 20,000 | $57.80 | $1.16M | 0 |
| Mar 1, 2021↗ | RUBINSTEIN JULIE | President | Sell | 15,000 | $58.32 | $874.7K | 0 |
| Feb 26, 2021↗ | RUBINSTEIN JULIE | President | Sell | 15,000 | $56.23 | $843.5K | 0 |
| Feb 26, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 2,812 | $55.53 | $156.1K | 0 |
| Feb 24, 2021↗ | RUBINSTEIN JULIE | President | Sell | 29,675 | $56.99 | $1.69M | 0 |
| Feb 22, 2021↗ | RUBINSTEIN JULIE | President | Sell | 30,000 | $57.58 | $1.73M | 0 |
| Feb 19, 2021↗ | BENZENO SHARON | Chief Business Development Off | Sell | 416 | $61.20 | $25.5K | 0 |
| Feb 19, 2021↗ | RUBINSTEIN JULIE | President | Sell | 15,000 | $62.29 | $934.4K | 0 |
ADPT Insider Buying Activity
The following table shows recent insider purchases of Adaptive Biotechnologies Corporation (ADPT) stock reported via SEC Form 4 filings.
No insider buying activity found for ADPT in the last 12 months.
ADPT Insider Selling Activity
The following table shows recent insider sales of Adaptive Biotechnologies Corporation (ADPT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026↗ | RUBINSTEIN JULIE | officer: President and COO | Sell | 81,342 | $14.90 | $1.21M | 652,147 |
| Mar 9, 2026↗ | LO FRANCIS | officer: Chief People Officer | Sell | 38,074 | $15.09 | $574.5K | 321,967 |
| Mar 5, 2026↗ | GRIFFIN MICHELLE RENEE | director | Sell | 48,044 | $15.30 | $735.1K | 15,394 |
| Mar 5, 2026↗ | RUBINSTEIN JULIE | officer: President and COO | Sell | 92,823 | $16.09 | $1.49M | 590,429 |
| Mar 4, 2026↗ | ROBINS HARLAN S | officer: Chief Scientific Officer | Sell | 48,466 | $16.19 | $784.7K | 1,169,520 |
| Mar 3, 2026↗ | ROBINS CHAD M | director, officer: CEO and Chairman | Sell | 1,049,996 | $15.85 | $16.64M | 2,276,350 |
| Feb 6, 2026↗ | PISKEL KYLE | officer: Chief Financial Officer | Sell | 2,145 | $18.46 | $39.6K | 216,637 |
| Feb 4, 2026↗ | PISKEL KYLE | Chief Financial Officer | Sell | 2,145 | $18.46 | $39.6K | 0 |
| Feb 4, 2026↗ | ROBINS CHAD M | director, officer: CEO and Chairman | Sell | 124,998 | $18.44 | $2.30M | 2,459,240 |
| Feb 4, 2026↗ | ROBINS HARLAN S | officer: Chief Scientific Officer | Sell | 42,788 | $18.68 | $799.1K | 1,187,640 |
| Feb 2, 2026↗ | ROBINS CHAD M | CEO and Chairman | Sell | 124,998 | $18.44 | $2.30M | 0 |
| Feb 2, 2026↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 42,788 | $18.68 | $799.1K | 0 |
| Jan 14, 2026↗ | LO FRANCIS | officer: Chief People Officer | Sell | 79,590 | $17.73 | $1.41M | 315,978 |
| Jan 14, 2026↗ | PISKEL KYLE | officer: Chief Financial Officer | Sell | 4,290 | $18.00 | $77.2K | 216,637 |
| Jan 12, 2026↗ | LO FRANCIS | Chief People Officer | Sell | 79,590 | $17.73 | $1.41M | 0 |
| Jan 12, 2026↗ | PISKEL KYLE | Chief Financial Officer | Sell | 4,290 | $18.00 | $77.2K | 0 |
| Jan 8, 2026↗ | ROBINS HARLAN S | officer: Chief Scientific Officer | Sell | 10,000 | $16.44 | $164.4K | 1,222,310 |
| Jan 7, 2026↗ | ROBINS CHAD M | director, officer: CEO and Chairman | Sell | 124,998 | $15.59 | $1.95M | 2,584,240 |
| Jan 6, 2026↗ | LO FRANCIS | officer: Chief People Officer | Sell | 3,125 | $16.08 | $50.3K | 315,978 |
| Jan 6, 2026↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 10,000 | $16.44 | $164.4K | 0 |
| Jan 5, 2026↗ | ROBINS CHAD M | CEO and Chairman | Sell | 124,998 | $15.59 | $1.95M | 0 |
| Jan 2, 2026↗ | LO FRANCIS | Chief People Officer | Sell | 3,125 | $16.08 | $50.3K | 0 |
| Dec 22, 2025↗ | LO FRANCIS | Chief People Officer | Sell | 4,394 | $17.50 | $76.9K | 0 |
| Dec 15, 2025↗ | LO FRANCIS | Chief People Officer | Sell | 113,890 | $15.57 | $1.77M | 0 |
| Dec 10, 2025↗ | HERSHBERG ROBERT | Director | Sell | 22,968 | $16.00 | $367.5K | 0 |
| Dec 4, 2025↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 12,604 | $16.85 | $212.4K | 0 |
| Dec 3, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 37,212 | $18.07 | $672.5K | 0 |
| Nov 28, 2025↗ | PISKEL KYLE | Chief Financial Officer | Sell | 162,820 | $19.50 | $3.17M | 0 |
| Nov 26, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 160,734 | $19.10 | $3.07M | 0 |
| Nov 20, 2025↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 606,402 | $16.73 | $10.14M | 0 |
| Nov 17, 2025↗ | PISKEL KYLE | Chief Financial Officer | Sell | 238 | $14.05 | $3.3K | 0 |
| Nov 10, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 89,265 | $14.73 | $1.32M | 0 |
| Nov 10, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 10,000 | $14.82 | $148.2K | 0 |
| May 15, 2025↗ | PISKEL KYLE | Chief Financial Officer | Sell | 1,929 | $8.89 | $17.1K | 0 |
| May 1, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 68,412 | $7.35 | $502.8K | 0 |
| Mar 24, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 1,698 | $9.00 | $15.3K | 0 |
| Mar 13, 2025↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 36,291 | $7.19 | $260.9K | 0 |
| Mar 12, 2025↗ | HERSHBERG ROBERT | Director | Sell | 53,000 | $7.59 | $402.3K | 0 |
| Mar 10, 2025↗ | NEUPERT PETER M | Director | Sell | 10,000 | $7.05 | $70.5K | 0 |
| Mar 4, 2025↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 44,665 | $6.98 | $311.8K | 0 |
| Mar 4, 2025↗ | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 26,023 | $6.98 | $181.6K | 0 |
| Mar 4, 2025↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 15,664 | $7.94 | $124.4K | 0 |
| Mar 4, 2025↗ | LO FRANCIS | Chief People Officer | Sell | 20,875 | $6.99 | $145.8K | 0 |
| Mar 4, 2025↗ | PISKEL KYLE | Chief Financial Officer | Sell | 10,320 | $6.98 | $72.1K | 0 |
| Mar 4, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 219,569 | $7.29 | $1.60M | 0 |
| Mar 4, 2025↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 96,656 | $6.99 | $675.2K | 0 |
| Mar 4, 2025↗ | RUBINSTEIN JULIE | President and COO | Sell | 59,505 | $6.98 | $415.5K | 0 |
| Feb 19, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 285,187 | $8.45 | $2.41M | 0 |
| Feb 13, 2025↗ | ROBINS CHAD M | CEO and Chairman | Sell | 470,368 | $8.47 | $3.99M | 0 |
| Nov 18, 2024↗ | PISKEL KYLE | Chief Financial Officer | Sell | 248 | $4.98 | $1.2K | 0 |
| Aug 22, 2024↗ | Taylor Stacy L | SVP and General Counsel | Sell | 26,922 | $4.50 | $121.1K | 0 |
| Mar 4, 2024↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 29,390 | $3.44 | $101.0K | 0 |
| Mar 4, 2024↗ | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | 12,991 | $3.44 | $44.6K | 0 |
| Mar 4, 2024↗ | LO FRANCIS | Chief People Officer | Sell | 14,700 | $3.43 | $50.4K | 0 |
| Mar 4, 2024↗ | PETERSON TYCHO | Chief Financial Officer | Sell | 15,456 | $3.44 | $53.2K | 0 |
| Mar 4, 2024↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 7,727 | $3.43 | $26.5K | 0 |
| Mar 4, 2024↗ | ROBINS CHAD M | CEO and Chairman | Sell | 48,673 | $3.43 | $167.0K | 0 |
| Mar 4, 2024↗ | RUBINSTEIN JULIE | President | Sell | 39,070 | $3.47 | $135.8K | 0 |
| Mar 4, 2024↗ | Taylor Stacy L | SVP and General Counsel | Sell | 13,381 | $3.43 | $46.0K | 0 |
| Nov 16, 2023↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 259 | $4.13 | $1.1K | 0 |
| Aug 7, 2023↗ | SOOD NITIN | Chief Commercial Officer, MRD | Sell | 16,202 | $6.62 | $107.3K | 0 |
| Jun 20, 2023↗ | PETERSON TYCHO | Chief Financial Officer | Sell | 134,961 | $8.14 | $1.10M | 0 |
| Jun 15, 2023↗ | PETERSON TYCHO | Chief Financial Officer | Sell | 70,000 | $8.53 | $597.1K | 0 |
| Jun 2, 2023↗ | PETERSON TYCHO | Chief Financial Officer | Sell | 38,000 | $7.16 | $272.1K | 0 |
| Apr 10, 2023↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $8.60 | $26.9K | 0 |
| Mar 27, 2023↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 2,341 | $8.49 | $19.9K | 0 |
| Mar 6, 2023↗ | ADAMS R MARK | Chief Operating Officer | Sell | 23,684 | $8.59 | $203.5K | 0 |
| Mar 6, 2023↗ | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sell | 11,749 | $8.57 | $100.7K | 0 |
| Mar 6, 2023↗ | LO FRANCIS | Chief People Officer | Sell | 6,816 | $8.57 | $58.4K | 0 |
| Mar 6, 2023↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 3,529 | $8.57 | $30.2K | 0 |
| Mar 6, 2023↗ | RUBINSTEIN JULIE | President | Sell | 22,668 | $8.57 | $194.3K | 0 |
| Mar 6, 2023↗ | SOOD NITIN | Chief Commercial Officer, MRD | Sell | 16,474 | $8.59 | $141.5K | 0 |
| Mar 6, 2023↗ | Taylor Stacy L | SVP and General Counsel | Sell | 18,878 | $8.59 | $162.2K | 0 |
| Jan 9, 2023↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $8.55 | $26.7K | 0 |
| Nov 16, 2022↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 959 | $8.87 | $8.5K | 0 |
| Nov 1, 2022↗ | SOOD NITIN | Chief Commercial Officer, MRD | Sell | 31,066 | $8.00 | $248.5K | 0 |
| Oct 7, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $7.26 | $22.7K | 0 |
| Aug 5, 2022↗ | SOOD NITIN | Chief Commercial Officer, MRD | Sell | 17,540 | $10.98 | $192.6K | 0 |
| Jul 7, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $10.22 | $31.9K | 0 |
| Apr 7, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 831 | $13.17 | $10.9K | 0 |
| Mar 8, 2022↗ | BALDO LANCE | Chief Medical Officer | Sell | 3,350 | $11.43 | $38.3K | 0 |
| Mar 8, 2022↗ | LO FRANCIS | Chief People Officer | Sell | 3,582 | $11.44 | $41.0K | 0 |
| Mar 8, 2022↗ | Taylor Stacy L | SVP and General Counsel | Sell | 2,387 | $11.44 | $27.3K | 0 |
| Mar 7, 2022↗ | BALDO LANCE | Chief Medical Officer | Sell | 2,373 | $12.01 | $28.5K | 0 |
| Mar 7, 2022↗ | ROBINS CHAD M | CEO and Chairman | Sell | 44,445 | $11.80 | $524.4K | 0 |
| Mar 4, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 1,244 | $12.01 | $14.9K | 0 |
| Mar 4, 2022↗ | BENZENO SHARON | Chief Business Development Off | Sell | 2,670 | $12.01 | $32.1K | 0 |
| Mar 4, 2022↗ | LO FRANCIS | Chief People Officer | Sell | 1,569 | $12.01 | $18.8K | 0 |
| Mar 4, 2022↗ | PISKEL KYLE | Principal Accounting Officer | Sell | 220 | $12.01 | $2.6K | 0 |
| Mar 4, 2022↗ | ROBINS CHAD M | CEO and Chairman | Sell | 4,424 | $12.01 | $53.1K | 0 |
| Mar 4, 2022↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 4,517 | $12.01 | $54.2K | 0 |
| Mar 4, 2022↗ | RUBINSTEIN JULIE | President | Sell | 4,613 | $12.01 | $55.4K | 0 |
| Mar 4, 2022↗ | Taylor Stacy L | SVP and General Counsel | Sell | 1,569 | $12.01 | $18.8K | 0 |
| Jan 7, 2022↗ | ADAMS R MARK | Chief Operating Officer | Sell | 1,021 | $23.32 | $23.8K | 0 |
| Dec 22, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $30.00 | $300.0K | 0 |
| Dec 22, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 15,338 | $30.00 | $460.1K | 0 |
| Nov 17, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 4,000 | $32.00 | $128.0K | 0 |
| Nov 9, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $34.98 | $349.8K | 0 |
| Oct 19, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,200 | $33.71 | $377.6K | 0 |
| Oct 7, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $33.16 | $103.6K | 0 |
| Oct 6, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $32.95 | $385.0K | 0 |
| Oct 5, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $32.41 | $324.1K | 0 |
| Sep 13, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $36.98 | $432.1K | 0 |
| Sep 8, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 43,499 | $38.43 | $1.67M | 0 |
| Sep 7, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 14,375 | $39.47 | $567.3K | 0 |
| Sep 7, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 495 | $40.00 | $19.8K | 0 |
| Aug 27, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 14,916 | $35.00 | $522.1K | 0 |
| Aug 25, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $34.25 | $400.2K | 0 |
| Aug 10, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 15,000 | $34.07 | $511.0K | 0 |
| Jul 19, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | Sell | 651 | $36.12 | $23.5K | 0 |
| Jul 19, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $37.47 | $437.9K | 0 |
| Jul 14, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 2,500 | $36.80 | $92.0K | 0 |
| Jul 12, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 1,501 | $38.24 | $57.4K | 0 |
| Jul 7, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,125 | $37.17 | $116.2K | 0 |
| Jul 6, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 20,000 | $38.68 | $773.6K | 0 |
| Jun 30, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 4,167 | $41.42 | $172.6K | 0 |
| Jun 17, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 14,583 | $40.00 | $583.3K | 0 |
| Jun 17, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 4,000 | $40.00 | $160.0K | 0 |
| Jun 17, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | Sell | 1,952 | $39.87 | $77.8K | 0 |
| Jun 17, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 4,166 | $40.00 | $166.6K | 0 |
| Jun 15, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 30,000 | $38.47 | $1.15M | 0 |
| Jun 14, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 8,914 | $38.77 | $345.6K | 0 |
| Jun 14, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 2,500 | $38.56 | $96.4K | 0 |
| Jun 9, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 11,685 | $37.32 | $436.1K | 0 |
| Jun 8, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 20,000 | $36.33 | $726.5K | 0 |
| May 18, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 2,500 | $35.00 | $87.5K | 0 |
| May 18, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | Sell | 651 | $35.00 | $22.8K | 0 |
| May 14, 2021↗ | LO FRANCIS | Chief People Officer | Sell | 2,000 | $33.80 | $67.6K | 0 |
| May 11, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 20,000 | $32.08 | $641.6K | 0 |
| May 5, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 7,090 | $35.58 | $252.2K | 0 |
| May 4, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 3,895 | $36.14 | $140.7K | 0 |
| Apr 30, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 4,166 | $41.93 | $174.7K | 0 |
| Apr 20, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 27,265 | $41.56 | $1.13M | 0 |
| Apr 19, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | Sell | 1,301 | $41.25 | $53.7K | 0 |
| Apr 15, 2021↗ | LO FRANCIS | Chief People Officer | Sell | 2,000 | $43.04 | $86.1K | 0 |
| Apr 14, 2021↗ | BALDO LANCE | Chief Medical Officer | Sell | 2,000 | $44.50 | $89.0K | 0 |
| Apr 14, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 4,500 | $43.41 | $195.3K | 0 |
| Apr 7, 2021↗ | ADAMS R MARK | Chief Operating Officer | Sell | 3,586 | $42.34 | $151.8K | 0 |
| Apr 6, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 20,000 | $41.30 | $826.0K | 0 |
| Apr 6, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 15,000 | $41.81 | $627.1K | 0 |
| Mar 31, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 4,167 | $40.00 | $166.7K | 0 |
| Mar 23, 2021↗ | ROBINS HARLAN S | Chief Scientific Officer | Sell | 19,475 | $40.36 | $786.1K | 0 |
| Mar 18, 2021↗ | Palaniappan Jyoti | SVP, Diagnostics, immunoSEQ Dx | Sell | 16,052 | $43.58 | $699.6K | 0 |
| Mar 17, 2021↗ | ROBINS CHAD M | CEO and Chairman | Sell | 15,000 | $42.89 | $643.4K | 0 |
| Mar 15, 2021↗ | BENZENO SHARON | Chief Business Development Off | Sell | 1,354 | $41.69 | $56.5K | 0 |
| Mar 15, 2021↗ | GRIFFIN MICHELLE RENEE | Director | Sell | 6,000 | $43.06 | $258.4K | 0 |
| Mar 15, 2021↗ | LO FRANCIS | Chief People Officer | Sell | 2,000 | $41.83 | $83.7K | 0 |
| Mar 10, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $42.54 | $425.4K | 0 |
| Mar 9, 2021↗ | Cohen Chad M | Chief Financial Officer | Sell | 10,000 | $40.24 | $402.4K | 0 |
| Mar 8, 2021↗ | GOEL DAVID E. | Director | Sell | 806,000 | $39.99 | $32.23M | 0 |
| Mar 8, 2021↗ | HERSHBERG ROBERT | Director | Sell | 4,000 | $44.56 | $178.2K | 0 |
| Mar 1, 2021↗ | BENZENO SHARON | Chief Business Development Off | Sell | 6,771 | $57.62 | $390.1K | 0 |
| Mar 1, 2021↗ | Pellini Michael J | Director | Sell | 20,000 | $57.80 | $1.16M | 0 |
| Mar 1, 2021↗ | RUBINSTEIN JULIE | President | Sell | 15,000 | $58.32 | $874.7K | 0 |
| Feb 26, 2021↗ | RUBINSTEIN JULIE | President | Sell | 15,000 | $56.23 | $843.5K | 0 |
| Feb 26, 2021↗ | Taylor Stacy L | SVP and General Counsel | Sell | 2,812 | $55.53 | $156.1K | 0 |
| Feb 24, 2021↗ | RUBINSTEIN JULIE | President | Sell | 29,675 | $56.99 | $1.69M | 0 |
| Feb 22, 2021↗ | RUBINSTEIN JULIE | President | Sell | 30,000 | $57.58 | $1.73M | 0 |
| Feb 19, 2021↗ | BENZENO SHARON | Chief Business Development Off | Sell | 416 | $61.20 | $25.5K | 0 |
| Feb 19, 2021↗ | RUBINSTEIN JULIE | President | Sell | 15,000 | $62.29 | $934.4K | 0 |
ADPT Insiders
Similar Stocks to ADPT
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B